Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.
作者信息
Gescher A
出版信息
Br J Cancer. 1992 Jul;66(1):10-9. doi: 10.1038/bjc.1992.209.
Abstract
摘要
相似文献
1
Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.迈向蛋白激酶C的选择性药理学调控——新型抗肿瘤药物研发的机遇
Br J Cancer. 1992 Jul;66(1):10-9. doi: 10.1038/bjc.1992.209.
2
[Protein kinase C. Key enzyme for immune reactions and cell growth].[蛋白激酶C。免疫反应和细胞生长的关键酶]
Med Monatsschr Pharm. 1994 Nov;17(11):326-8.
3
4
Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Leuk Lymphoma. 1993 Jan;9(1-2):141-8. doi: 10.3109/10428199309148517.
5
Chemistry and clinical biology of the bryostatins.
Bioorg Med Chem. 2000 Aug;8(8):1841-60. doi: 10.1016/s0968-0896(00)00150-4.
6
7
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.建立对苔藓抑素1生长抑制作用具有抗性的小鼠白血病细胞系。
Br J Cancer. 1994 Oct;70(4):573-8. doi: 10.1038/bjc.1994.353.
8
9
Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.苔藓抑素1使人类宫颈癌细胞对顺二氯二氨铂（II）敏感化。
Cancer Res. 1992 Jun 1;52(11):3119-24.
10
Protein kinase C-alpha in prostate cancer.蛋白激酶C-α与前列腺癌
BJU Int. 2004 May;93(7):1076-81. doi: 10.1111/j.1464-410X.2003.04784.x.
引用本文的文献
1
Angiotropic metastatic malignant melanoma in a canine mammary gland.犬乳腺中亲血管转移性恶性黑色素瘤
Lab Anim Res. 2011 Dec;27(4):353-6. doi: 10.5625/lar.2011.27.4.353. Epub 2011 Dec 19.
2
Protein kinase C: a family of isoenzymes with distinct roles in pathogenesis.蛋白激酶C：一组在发病机制中具有不同作用的同工酶家族。
Clin Mol Pathol. 1995 Apr;48(2):M57-64. doi: 10.1136/mp.48.2.m57.
3
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas.抗蛋白激酶C-α反义寡核苷酸阿普瑞司他（aprinocarsen）以21天持续静脉输注方式给药，用于复发性高级别星形细胞瘤患者的疗效和毒性。
Neuro Oncol. 2005 Jan;7(1):32-40. doi: 10.1215/S1152851703000353.
4
Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target.在表达突变型ras癌基因的人上皮细胞中通过刺激蛋白激酶C诱导细胞死亡：一个潜在的治疗靶点。
Br J Cancer. 1998 Sep;78(5):641-51. doi: 10.1038/bjc.1998.554.
5
Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitro.苔藓抑素1-他莫昔芬组合在体外对P388细胞生长的抑制作用显示出协同效应。
Br J Cancer. 1998;77(2):216-20. doi: 10.1038/bjc.1998.36.
6
Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential.具有高转移潜能的小鼠黑色素瘤细胞中蛋白激酶C-α亚型的激活
Clin Exp Metastasis. 1997 Nov;15(6):568-79. doi: 10.1023/a:1018447531813.
7
Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.蛋白激酶C的同工酶：在细胞凋亡和发病机制中的不同作用
Mol Pathol. 1997 Jun;50(3):124-31. doi: 10.1136/mp.50.3.124.
8
Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro.体外苔藓抑素刺激的原发性B慢性淋巴细胞白血病细胞中的早期反应基因信号传导
Biochem J. 1996 Oct 1;319 ( Pt 1)(Pt 1):59-65. doi: 10.1042/bj3190059.
9
Emerging drug treatments for solid tumours.实体瘤的新兴药物治疗方法。
Drugs. 1996 Jan;51(1):45-72. doi: 10.2165/00003495-199651010-00005.
10
Establishment of a murine leukaemia cell line resistant to the growth-inhibitory effect of bryostatin 1.建立对苔藓抑素1生长抑制作用具有抗性的小鼠白血病细胞系。
Br J Cancer. 1994 Oct;70(4):573-8. doi: 10.1038/bjc.1994.353.
本文引用的文献
1
2
Modes of inhibition by acylcarnitines, adriamycin and trifluoperazine of cardiac phospholipid-sensitive calcium-dependent protein kinase.酰基肉碱、阿霉素和三氟拉嗪对心脏磷脂敏感性钙依赖性蛋白激酶的抑制模式。
Biochem Pharmacol. 1983 Apr 1;32(7):1259-65. doi: 10.1016/0006-2952(83)90280-0.
3
Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.佛波酯增加了与质膜相关的Ca2+、磷脂依赖性蛋白激酶的量。
Nature. 1983;301(5901):621-3. doi: 10.1038/301621a0.
4
Phorbol diesters and cellular differentiation.佛波酯与细胞分化
J Natl Cancer Inst. 1984 Nov;73(5):1013-9.
5
Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.异喹啉磺酰胺，新型强效环核苷酸依赖性蛋白激酶和蛋白激酶C抑制剂。
Biochemistry. 1984 Oct 9;23(21):5036-41. doi: 10.1021/bi00316a032.
6
Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells.佛波酯处理的3T3细胞中钙敏感、磷脂依赖性蛋白激酶活性的消失。
Biochem Biophys Res Commun. 1984 May 16;120(3):1053-9. doi: 10.1016/s0006-291x(84)80213-2.
7
Antineoplastic components of marine animals.海洋动物的抗肿瘤成分。
Nature. 1970 Aug 29;227(5261):962-3. doi: 10.1038/227962a0.
8
Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.苔藓抑素：强效新型有丝分裂原，可模拟佛波酯肿瘤启动子
Biochem Biophys Res Commun. 1985 Nov 15;132(3):939-45. doi: 10.1016/0006-291x(85)91898-4.
9
Protein kinase C contains a pseudosubstrate prototope in its regulatory domain.蛋白激酶C在其调节结构域中含有一个假底物原基。
Science. 1987 Dec 18;238(4834):1726-8. doi: 10.1126/science.3686012.
10
Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.苔藓抑素1是一种蛋白激酶C激活剂，可抑制佛波酯在SENCAR小鼠皮肤中的肿瘤促进作用。
Carcinogenesis. 1987 Sep;8(9):1343-6. doi: 10.1093/carcin/8.9.1343.
Zotero 插件